WEST PHARMACEUTICAL SERVICES, INC. Deferred Compensation Plan Assets
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Deferred Compensation Plan Assets of $9.90 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes
us-gaap:DeferredCompensationPlanAssets · last filed 2026-07-23
- 2026-06-30: Deferred Compensation Plan Assets $9.90M.
- 2026-03-31: Deferred Compensation Plan Assets $8.70M.
- 2025-12-31: Deferred Compensation Plan Assets $10.00M.
- 2025-09-30: Deferred Compensation Plan Assets $10.00M.
| Period end | Deferred Compensation Plan Assets |
|---|---|
| 2026-06-30 | $9.90M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $8.70M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $10.00M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $10.00M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $9.50M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $8.50M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $11.10M 10-K · filed 2026-02-17 |
| 2024-09-30 | $11.30M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $10.40M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $9.90M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $10.20M 10-K · filed 2025-02-18 |
| 2023-09-30 | $9.10M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $11.10M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $10.40M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $12.50M 10-K · filed 2024-02-20 |
| 2022-09-30 | $12.30M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $12.90M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $15.00M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $15.50M 10-K · filed 2023-02-21 |
| 2021-09-30 | $14.40M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $14.60M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $13.30M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $12.80M 10-K · filed 2022-02-22 |
| 2020-09-30 | $11.20M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $11.00M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $9.30M 10-Q · filed 2020-04-24 |
| 2019-12-31 | $11.30M 10-K · filed 2021-02-23 |
| 2019-09-30 | $9.90M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $9.20M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $9.20M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $8.70M 10-Q · filed 2019-10-29 |
| 2018-09-30 | $9.40M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $8.80M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $8.30M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $8.90M 10-Q · filed 2018-10-30 |
| 2017-09-30 | $8.50M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $8.00M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $7.50M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $7.40M 10-Q · filed 2017-10-31 |
| 2016-09-30 | $6.40M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $6.40M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $6.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $6.80M 10-Q · filed 2016-10-31 |
| 2015-09-30 | $6.40M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $6.90M 10-Q · filed 2015-08-03 |
| 2015-03-31 | $6.60M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $6.60M 10-Q · filed 2015-11-02 |
| 2014-09-30 | $6.10M 10-Q · filed 2014-11-03 |
| 2014-06-30 | $6.10M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $5.80M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $5.70M 10-Q · filed 2014-11-03 |
| 2013-09-30 | $5.20M 10-Q · filed 2013-11-04 |
| 2012-12-31 | $4.00M 10-Q · filed 2013-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |